Strength | 60 mg |
Packaging Size | 10*10 Tablets |
Packaging Type | Box |
Composition | Raloxifene Hydrochloride 60mg |
Brand | Ralista |
Manufacturer | Cipla |
Shelf Life | 24 Months |
Prescription/Non-Prescription | Prescription |
Raloxifene, sold under the brand name Evista among others, is a medication which is used in the prevention and treatment of osteoporosis in postmenopausal women and to reduce the risk of breast cancer in postmenopausal women with osteoporosis or at high risk for breast cancer.[3][4] It is taken by mouth.[3]
Side effects of raloxifene include hot flashes, leg cramps, and an increased risk of blood clots and other cardiovascular events such as stroke.[3][4] The drug is a selective estrogen receptor modulator(SERM) and hence is a mixed agonist–antagonist of the estrogen receptor (ER), the biological targetof estrogens like estradiol.[5][6][7] It has estrogenic effects in bone and the liver and antiestrogeniceffects in the breasts and uterus
SKU-VGXM0AWAIBKOStrength | 60 mg |
Packaging Size | 10*10 Tablets |
Packaging Type | Box |
Composition | Raloxifene Hydrochloride 60mg |
Brand | Ralista |
Manufacturer | Cipla |
Shelf Life | 24 Months |
Prescription/Non-Prescription | Prescription |
Raloxifene, sold under the brand name Evista among others, is a medication which is used in the prevention and treatment of osteoporosis in postmenopausal women and to reduce the risk of breast cancer in postmenopausal women with osteoporosis or at high risk for breast cancer.[3][4] It is taken by mouth.[3]
Side effects of raloxifene include hot flashes, leg cramps, and an increased risk of blood clots and other cardiovascular events such as stroke.[3][4] The drug is a selective estrogen receptor modulator(SERM) and hence is a mixed agonist–antagonist of the estrogen receptor (ER), the biological targetof estrogens like estradiol.[5][6][7] It has estrogenic effects in bone and the liver and antiestrogeniceffects in the breasts and uterus